Bioactives in rice bran and rice bran oil

Phytochemicals as Bioactive Agents

Volumn , Issue , 2000, Pages 213-240

  Cheruvanky, Rukmlnl ^a  

^a The RiceX Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CHEMICAL CONTAMINATION; COMMERCE; DISEASES; OILS AND FATS; PLANTS (BOTANY);

ASIAN COUNTRIES; CARDIO-VASCULAR DISEASE; CAUSES OF DEATH; DISEASE PREVENTION; FOOD INGREDIENTS; NUTRACEUTICAL PRODUCTS; NUTRITIVE VALUES; SCIENTIFIC EVIDENCE;

FUNCTIONAL FOOD;

EID: 85018108663     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (75)

1. Beg, Z.H., Timani, K.A., and Khan, S.Z. 1996. Impact of dietary rice bran oil on cholesterol dynamics in normolipidemic and hyperlipidemichumans and hyperlipidemic rats. FASEB. J.10(3):A187.
2. Berges, R.R., Windeler, J., and Trampsch, R.J. 1995. Randomized placebo-controlled, doubleblind clinical trial of β-sitosterol in patients with benign prostatic hyperplasia. The Lancet. 345:1529-1532.
3. Bloch, A., Cynthia, A., and Thompson, A. 1997. Position of the American Dietetic Association: phytochemicals and functional foods. J. Nutr. Func. & Med. Foods. 1(1):33-45
4. Bruni, J. 1988. Monograph on Gamma Oryzanol: The Facts. Houston, TX: Claudell Publishers, pp. 1–62.
5. Childs, N.M. 1997. Nutraceuticals and functional foods—an introduction to the present status and key issues. J. Nutraceuticals, Functional and Medical Foods. 1(1):7-9.
6. Chim, H., Cillard, J., Cillard, P., and Rahmani, M. 1991. Polyphenols have the ability to block specific enzymes that cause inflammation. J. Amer. Oil Chem. Soc. 71:427.
7. Datta, R., Hallahan, D.E., Kharbanda, S.M., Rubin, E., Sherman, M.I., Huberman, E., Weishelbaum, R.R., and Kufe, D.W. 1992. Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation. Biochemistry. 31:8300-8306.
8. DeFelice, L.S. 1998. Where is the first nutraceutical cereal company? Cereal World. 43(5):351-365.
9. Devary, Y., Gottilieb R.A., Smeal, T., and Karin, M. 1992. The mammalian ultraviolet response is triggered by activation of src tyrosine kinase. Cell. 71:1081-1091.
10. Eisenberg, D.M., Kessler, R.C., Foster, C., Norlock, F.E., Calkins, D.R., and Delbanco, T.L. 1993. Unconventional medicine in the United States. New England J. Med. 328:246-262.
11. Fiala, E.S., Reddy, B.S., and Weisberger, J.H. 1995. Naturally occurring anticarcinogenic substances in foodstuffs. Ann. Rev. Nutri. 5:295.
12. Food and Agricultural Organization (Rome) Database. 1998. World Production of Agricultural Produce—Rice, Rice Bran and Rice Bran Oil, a report.
13. Fritsch, C.W. and Gale, J.A. 1977. Hexanal as a measure of rancidity in low fat foods. J. Amer. Oil Chem. Soc. 54:225-228.
14. Fukushi, J. 1996. Edible rice bran oil 111, antioxidant effect of γ-oryzanol. Hokkaido-ritsu Elsei. Kenkyushoho. 16:111.
15. Garewell, A.S. (Ed). 1997. Antioxidants in Disease Prevention. Boca Raton, FL: CRC Press.
16. Gerhardt, A.L. and Gallo, N.B. 1998. Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans. The Journal of Nutrition. 128(5):865-869.
17. Goldberg, I., Ed. 1994. Functional foods, designer foods, pharma foods, nutraceuticals New York: Chapman & Hall.
18. Graf, E. 1992. Antioxidant potential of ferulic acid., free radical. Biol. & Med. 13(4):435-448.
19. Hargrove, K.L. Jr. 1994. Processing and utilization of rice bran in the United States. In: Rice Science and Technology. Marshall, E.W. and J.I. Wadsworth (Eds). New York: Marcell Dekker, Chapter 16, pp. 381–404.
20. Hegsted, M. and Kousik, C.S. 1994. Rice bran and rice bran oil may lower heart disease risk by decreasing cholesterol synthesis in the body. Lousiana Agriculture. 37(2):16-17.
21. Hegsted, M. and Windhauser. M. Rice bran and rice bran oil, a human study. Lousiana Agriculture. 37(2):23-24.
22. Helm, R.M. and Burks, A.W. 1996. Hypoallergenicity of rice proteins. Cereal Foods World. 41(11):839-843.
23. Hettiarachchy, N.S. and Gnanasambandam, R. 1994. Simple method(s) to determine rice quality and investigations of novel, value-added uses of rice bran. Part B. Value-added use of rice bran: protein concentrates and extracts with antioxidant activity. Arkansas Rice Research Studies. Arkansas Experimental Station Research Series, pp. 238–247.
24. Juliano, B.O. and Bechtel, D.B. 1985. The rice grain and its gross composition. In: Rice Chemistry and Technology. B.O. Juliano (Ed). St. Paul, MN: American Association of Cereal Chemists Inc., Chapter 2, pp. 17–57.
25. Krinsky. N.I. 1993. β-Carotene and colecteral, prostate cancer prevention. Rev. Nutri. 13:561-587.
26. Kritchevsky, D. and Bonafield, C. (Eds). 1995. Dietary Fiber in Health and Disease. St. Paul, MN: Eagan Press.
27. Lichtenstein, A.H., Ausman, L.M., Carrasco, W., Gualleiri, L.J., Jenner, J.L., Ordovas, J.M., Nicolosi, R.J., Goldin, B.R., and Schaefer, E.J. 1994. Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans. Artereosclerosis and Thrombosis. 14(4):549-556.
28. Lin, J.K., Lee, S.F., Huang, V.T., and Lin-Shiau, S.Y. 1995. Signal transduction and oncogene expression mediated by reactive oxygen species. In Proceedings of the International Symposium on Natural Antioxidants-Molecular Mechanisms and Health Effects Champaign, IL: AOCS Press, Chapter 33, pp. 303–315.
29. Manorama, R. 1993. Hepatic Drug Metabolizing Enzymes of Rice Bran Oil Fed Rats. (Ph.D. Thesis).
30. Meydani, M. 1995. Vitamin E. The Lancet. 345:170-175.
31. Mock, D.M. 1996. Biotin. In Present Knowledge in Nutrition, Ziegler, E.E., and Filer Jr, L.J. (Eds) Seventh Ed., Washington, DC: ILSI Press pp. 220–235.
32. Morita, S. 1986. Cosmetic creams containing γ-oryzanol. Japanese Patent No. 8665810.
33. Murthy, M. 1997. Nutraceuticals, functional foods and medical foods: commentary and caveats. J. Nutraceuticals, Functional & Medical Foods, Product Development, Commercialization and Policy Issues. 1(3):73-99.
34. Nakazawa, S., Imai, K., and Yamamoto, Y. 1977. Clinical studies on γ-oryzanol in the treatment of autonomic instability with abdominal symptoms. Japanese J. Psychosom. Med. 17(4): 101.
35. Nesaratnam, K., Stephen, R., Dils, R., and Darbre 1998. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids. 33(5):461-469.
36. Nicolosi, R.J., Ausman, L.M., and Hegsted, M. 1991. Rice bran oil lowers serum total and LDL lipoprotein cholesterol and apo B levels in non human primates. Atherosclerosis 88(2-3):133-142.
37. Oliver, M.F. 1984. Strategy of reducing coronary risk and the use of drugs. J. Cardiovascular. Pharm. 6:S880.
38. Orthoefer, F.T. 1996. Rice bran oil: a healthy lipid source. Food. Technology. 50(12):62-64.
39. Ozer, N.K., Palloza, P., and Boscoboinik, D. 1993. d-α-Tocopherol inhibit LDL-induced proliferation and protein kinase c-activity in vascular smooth muscle cells. FEBS. Lett. 322:307-310.
40. Packer, L. 1995. Cell regulation by thiol antioxidants from glutathione to lipoate to anethole dithiolethione. In Antioxidants. Molecular Mechanisms and Health Effects. Packer, L. Maret, G., Taber, and Wenjuan Xin (Eds). June 20-24, 1995, Beijing, China. Sponsored by UNESCO-MCBN, Champaign, IL: AOCS Press, Chapter 23, pp. 223–235.
41. Pillayar, P. 1978. Stabilization of rice bran, existing knowledge and lack of application. J. Agri. Eng 15(4): 165—173 (Review).
42. Polasa, K. and Rukmini, C. 1987. Mutagenicity tests of cashunut shell liquid, rice bran oil and other vegetable oils, using the Salmonella typhimurium/microsome system Food. Chem. Toxicol. 25(10):763-766.
43. Prakash, J. 1996. Rice bran proteins:properties and food uses. Critical Reviews in Food Science and Nutrition. 36(6):537-552.
44. Purushothama, S., Raina, P.L., and Hariharan, K. 1995. Effect of long term feeding of rice bran oil on lipids and lipoproteins in rats. Mol. & Cellular Biochem. 146(l):63-69.
45. Qureshi, N. and Qureshi, A.A. 1992. Tocotrienols: novel hypocholesterolemic agents with antioxidant properties. In Vitamin E in Health and Disease, Packer, L. and Fuch, J., Eds. New York: Marcel Dekker, Inc., pp. 45–267.
46. Qureshi, A.A., Burger, W.C., Peterson, D.M., and Elson, C.E. 1986. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J. Biol. Chem. 261:10544-10550.
47. Raghuram, T.C., Brahmaji Rao, U., and Rukmini, C. 1989. Studies on the hypolipidemic effects of dietary rice bran oil in human subjects. Nutrition Reports International 39:889-895.
48. Ramaratnam, N., Osawa, T., Namiki, M., and Tashiro, T. 1986. Studies on the relationship between antioxidant activity of rice hull and the germination ability of rice seeds. J. Food. Sci. Agi. 37(8):719.
49. Reddysastry, C. and Rukmini, C. 1997. Stability studies on RiceX® rice bran under accelerated conditions for twelve weeks, (Unpublished).
50. Rindi, G. 1996. Thiamin. In Present Knowledge in Nutrition. Ziegler, E.E., and Filer L.J. Jr, (Eds) Seventh Ed., Washington, DC. ILSI Press pp. 160–166.
51. Rong, N., Ausman, L.M., and Nicolosi, R.J. 1997. γ-Oryzanol decreases cholesterol absorption andaortic streaks in hamsters. Lipids. 32(3):303-309.
52. Rukmini, C. 1998, Unpublished.
53. Rukmini, C. and Kalpagam, P. 1985. Antimutagenic property of the unsaponifiable portion of rice bran oil. In Antimutagenesis and Anticarcinogenesis Mechanisms. Shankel, D.M., Hartman, P.E., Kada, T. and Hollaender, A., Eds. New York: Plenum Press, pp. 576.
54. Rukmini, C. and Raghuram, T.C. 1991. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review. J. Amer. Coll. Nutrition. 10:366.
55. Saunders, R.M, 1986. Rice bran: composition and potential food uses. Food. Rev. Int. 8:415-498.
56. Saura-Calixto, F. 1998. Antioxidant dietary fiber product: a new concept and a potential food ingredient. J. Agri. Food Chem. 46:4303-4306.
57. Seetharamiah, G.S. and Chandrasekhara, N. 1988. Hypocholesterolemic activity of γ-Oryzanol in rats. Nutrition Reports International. 38(5):927-935.
58. Seetharamiah, G.S. and Chandrasekhara, N. 1989. Studies on hypocholesterolemic activity of rice bran oil. Atherosclerosis. 78:219-223.
59. Seetharamiah, G.S. and Chandrasekhara, N. 1990. Effect of γ-Oryzanol on cholesterol absorption and biliary and fecal bile acids in rats. Ind. J. Med. Res. 92:471-475.
60. Shamsuddin, A.K. 1995. Inositol phosphate has novel anti-cancer function. J Nutri. 125:725s-732s.
61. Shamsuddin, A.M., Vucenik, I., and Cole, K.E. 1997. Minireview: IP6: a novel anti-cancer agent. Life Sciences. 61(4):343-354.
62. Sharma, R.D. and Rukmini, C. 1987. Hypocholesterolemic activity of unsaponifiable matter of rice bran oil. Ind. J. Med. Res. 85:278-281.
63. Sharma, R.D. and Rukmini, C. 1986. Rice branoil and hypocholesterolemia in rats. Lipids. 21(11):715-717.
64. Shin, T.S., Godber, S.J., Martin, D.E., and Wells, H.J. 1997. Hydrolytic stability and changes in vitamers and oryzanol of extruded rice bran during storage. J. Food Sci. 62(4):704—729.
65. Sugano, M. and Tsuji, E. 1997. Rice bran oil and cholesterol metabolism. J. of Nutrition.127(3):521S-524S.
66. Suzuki, S. and Oshima, S. 1970. Influence of blending edible fats and oils on serum cholesterol levels in humans. (Part 1) Japanese J. of Nutrition. 28:3; Part 11 28:194.
67. Suzuki, S., Tezuka, T., Oshima, S., Kuga, S., and Milani, M. 1984. Influence of several dietary lipids on human cholesterol. Oils & Fats (Japan). 37:42;37:59.
68. Tamagava, M., Shimizu, Y., Takahashi, T., Otaka, T., Kimura, S., Kadowaki, H., Uda, F., and Miwa, T. 1992. Carcinogenicity study of gamma oryzanol in F344 rats. Food Chemical Toxicology. 30(1):41-48.
69. Tsushimoto, G., Shibahara, T., Awogi, T., Kaneko, E., Sutou, S., Yamamoto, K., and Shirakawa, H. 1991. DNA-damaging. Mutagenic, clastogenic and cell-cell communication inhibitory properties of γ-Oryzanol. J. Toxicol. Sci. 16:191-202.
70. Weststrate, J.A. and Meijer, G.W. 1998. Plant sterol enriched margarines and reduction of plasma total, LDL-cholesterol concentrations in normocholesterolemic and mildly hypercholesterol-emic subjects. Eur. J. Clin. Nutri. 52:5, 334-343.
71. Wood, A.W., Huang, M.T., Chang, R.L., Newmark, H.L., Lehr, R.E., Yagi, H., Sayer, J.M., Jerina, D.M., and Conney, A.H. 1982. Inhibition of the mutagenicity of bay-region diol-epoxide of polycyclic aromatic hydrocarbons by naturally occurring plant polyphenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sci. USA 79:5513.
72. Yajnik, C.S., Smith, R.F., Hokaday, T.D.R., and Ward, N.I. 1984. Fasting plasma magnesium concentrations and glucose disposal in diabetics. British. Med. J. 288:1027-1028.
73. Yoshino, G., Kazumi, T., Amano, T., Tateiwa, M., Yamasaki, T., Takashima, S., Iwai, M., Hatanaka, H., and Baba, S. 1989. Effect of oryzanol on hypolipidemic subjects. Curr. Therapeutics. Res., 45(4):543-550.
74. Zambotti, V., Preti, A., and Berra, B. 1975. Influence of cycloartenol on cholesterol metabolism in rats. Proc. Second Intr. Congress on the Biological Value of Olive Oil, pp. 399–407.
75. Zimmerman, R. and Cerutti, P. 1984. Active oxygen acts as a promotor of transformation of mouse embryo C3H/10TI/2/C18 fibroblasts, Proc. Nat. Acad. Sci. USA. 81:2085-2087.